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Abstract
We present here a case of young male with complaints of fever and swelling in the neck for eight months. History
of progressive weakness associated with weight loss was present. Physical examination revealed pallor, multiple
enlarged cervical lymph nodes and hepatosplenomegaly. Investigations showed pancytopenia, hyperglobinemia
and Leishman-Donovan bodies on bone marrow aspiration. Serological test confirmed diagnosis of visceral
leishmaniasis. However, cervical lymph node aspiration and biopsy were suggestive of Mixed cellularity Hodgkin’s
disease. This made it a very rare case of Leishmaniasis as an opportunistic infection in a patient of pre-
chemotherapy Hodgkin’s disease. There was marked improvement in haematological profile and regression of
hepatosplenomegaly with Amphotericin B treatment followed by favourable response to chemotherapy. The case
emphasizes the suspicion for leishmaniasis as a masquerader and as an opportunistic infection in haematological
malignancies.
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Leishmaniasis is frequently reported in patients with
immunocompromised states due to HIV infection, post
organ transplantation, solid tumors and chemotherapy
[1,2]. However there are very few case reports of leish-
maniasis with haematological malignancies, and even
fewer with lymphoma, particularly Hodgkin’s disease
[3-6]. To the best of our knowledge, there are three case
reports of leishmaniasis in post-chemotherapy Hodgkin’s
disease patients and only two case reports [7,8] of leish-
maniasis in patients of Hodgkin’sd i s e a s e ,p r e - c h e -
motherapy [9]. The case presented herein is a rare case
of association of visceral leishmanisis and Hodgkin’s dis-
ease right from the beginning and delves into the patho-
logical and practical implications of their coexistence
[10,11].
The patient, 18-year-old male, presented with a his-
tory of fever and multiple swellings in left side of neck
for last eight months. Fever was moderate-to-high
grade, intermittent, associated with sweating, without
any chills or rigors. The patient noticed progressively
enlarging swellings in the left side of neck which were
painless, without any change on the overlying skin. In
the last two months, the patient also experienced easy
fatigability, weakness and swelling in both feet. Patient’s
father noticed weight loss which was not documented.
The patient had been on irregular treatment from local
practitioner without any relief in symptoms. The patient
did not give any history of tuberculosis or any other sys-
temic illness. There was no history of sexual contact,
blood transfusion, or drug addiction and no significant
family history was present.
On general physical examination, the patient was con-
scious, alert, and was of thin built. Vitals were stable
and body temperature was 39°C. Marked pallor was pre-
sent with pitting pedal edema. There were multiple
enlarged cervical lymph nodes in posterior triangle of
the neck on left side. Lymph nodes were firm in consis-
tency, varied in size (2-4 cm), were discrete and were
mobile, with normal overlying skin and temperature. On
systemic examination, only mild hepatomegaly and
moderate splenomegaly were seen.
Laboratory reports revealed pancytopenia with haemo-
globin of 2.7 gm/dl, platelet count of 1.31 lacs, leucocyte
count of 3500, ESR-70, and peripheral smear showed
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were raised with albumin being low (2 gm/dl). Ultraso-
nography of abdomen revealed hepatomegaly (liver span
18 cm) and splenomegaly (splenic span 20 cm). Other
investigations including chest X-ray, electrocardiogra-
phy, viral markers and HIV serology were normal.
CECT chest and abdomen revealed hepatosplenomegaly,
minimal ascites and minimal pleural effusion. Echocar-
diography was essentially normal. FNAC of cervical
lymph node was inconclusive and was repeated followed
by excision biopsy. Meanwhile, bone marrow aspiration
was done, which showed intracellular and extracellular
Leishman-Donovan bodies (Figure 1). This was followed
by a positive serology test for leishmaniasis. Patient was
immediately started on Amphotericin B and given three
units of blood transfusions. FNAC and excision biopsy
reports confirmed the diagnosis of Mixed cellularity
Hodgkin’s disease (Figure 2 and 3), making it an excep-
tional coexisting pathology. Marked clinical and hemato-
logical improvement was seen, with regression of
hepatosplenomegaly. The patient received three cycles
of chemotherapy and showed positive response.
The clinical forms of leishmaniasis are visceral leish-
maniasis (VL), cutaneous leishmaniasis (CL) and muco-
cutaneous leishmaniasis (ML). Out of 1.5-2 million
infected patients worldwide, 90% of CL cases are in the
e n d e m i cz o n eo fA f g h a n i s t a n ,P a k i s t a n ,M i d d l eE a s t ,
Brazil and Peru. However, 90% of VL cases are seen to
occur in the endemic zone of India, Bangladesh, Nepal,
Sudan and Brazil. Cervical lymphadenopathy is uncom-
mon in India though common in Mediterranean coun-
tries, Africa and China. On the other hand, incidence of
malignancy is 11 million new cases per year, worldwide,
with many cases occurring in the endemic zone of leish-
maniasis. Moreover, the medical management of malig-
nancy induces further immunosuppression, a condition
which is already present in the setting of lymphoma and
leukaemia, and becomes a breeding ground for opportu-
nistic infections like leishmaniasis.
Leishmaniasis has emerged as a severe opportunistic
infection in endemic areas. In immunocompromised
hosts, it can be asymptomatic, often with no splenome-
galy, and may be present in unusual location and run a
severe and refractory course with frequent relapse.
Although leishmaniasis and cancer are very common
diseases, little attention has been paid to the pathophy-
siological and practical implications of their co-exis-
tence. Leishmaniasis is recognized as an opportunistic
infection in HIV and malignancy patients [1,2], but
reports with lymphoma are scarce [3-5]. There are three
case reports of leishmaniasis in post chemotherapy
Hodgkin’s disease patients, including the recently pub-
lished study on coexistence of both in a single lymph
node, after multiple cycles of chemotherapy [6]. To the
best of our knowledge, there are only two case reports
[7,8] (Benhamou et al [7] and Magnan et al [8]) of
 
Figure 1 Bone marrow slides showing Leishman-Donovan
bodies (arrow).
 
Figure 2 Mixed cellularity seen in Hodgkin’s disease.
 
 
Figure 3 Immunohistochemistry showing CD30 marker (arrow)
in the lymph node.
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similar to our case.
In a significant review involving 37 case studies and 44
patients, Kopterides et al (2007)[9] found four types of
association between leishmaniasis and malignant disor-
ders: 1) Leishmaniasis masquerading as a malignant dis-
order, 2) Leishmaniasis developing as a difficult-to-
diagnose/treat infection among patients receiving che-
motherapy for various malignant disorders; 3) Simulta-
neous diagnosis of leishmaniasis and a neoplastic
disorder in the same tissue samples of immunocompro-
mised patients, and 4) Direct involvement of Leishmania
spp. in the pathogenesis of cancerous lesions. Mangoud
et al [10] reported that dysplasia was detected surround-
ing the leishmanial ulcer in 5 of 35 CL cases. Leishma-
niasis adversely affects the activation and function of
macrophages and dendritic cells [11], permitting the
escape of malignant cells from immune destruction.
Further, chronic leishmanial infections cause CD4 lym-
phopenia and low CD4/CD8 ratio. Similarly, Hodgkin’s/
Reed-Stenberg cells induce regulatory T cells that impair
adaptive immune responses by releasing IL-10 and TNF
B. Both the cytokines block the activation of naive and
effector T cells, and have been reported to suppress the
immune response to leishmania. Hence, mutual immu-
nomodulation of leishmaniasis and Hodgkin’s disease is
highlighted in this patient and requires further epide-
miological and pathology studies to understand the
exact association or causal relation.
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